PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), a leading specialty finance company providing growth capital to venture capital and private equity backed technology and life science companies, today announced that on March 19, 2007, it provided $10 million of debt financing to Memory Pharmaceuticals, Corp. (NASDAQ:MEMY), a publicly traded developer of innovative drugs for the treatment of debilitating central nervous system (CNS) disorders.
